SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Cistron Biotechnology(CIST)$.30 -- Ignore unavailable to you. Want to Upgrade?

To: Steve Harmon who wrote (1383)8/31/1998 12:51:00 PM
From: Steve Harmon  Respond to of 2742
 
Cistron is trading as if it were a Russian biotech company with 13 million rubles instead of dollars.

And just lost a major vaccine company sponsorship instead of picking up one.



To: Steve Harmon who wrote (1383)8/31/1998 5:58:00 PM
From: Chris W.  Read Replies (1) | Respond to of 2742
 
Doesn't Bluestone have a legal responsibility to avoid such an obvious conflict of interest before taking on their responsibilities to Cistron (and by extension Cistron's investors). It would seem to me that you can't play the game that way. I'll bet a good lawyer could find it in the law somewhere. But then again, maybe I am just a naive optimist


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News